More than 120 clinicians, researchers, and patient representatives gathered in Prague for the ERS/COPD-iNET Seminar to discuss new scientific and therapeutic approaches to COPD.
Researchers at the CPC-M site of the German Center for Lung Research (DZL), together with partner institutions, have published a new study presenting a promising therapeutic strategy for allergic asthma.
In 2025, researchers from the German Center for Lung Research (DZL) are once again counted among the world’s most influential scientists. This year, a total of eight DZL researchers were included by Clarivate Analytics in...
Post-COVID – also known as Long COVID – affects millions of people worldwide and causes persistent symptoms, the underlying mechanisms of which are still not fully understood. An interdisciplinary research team has now identified new...
Mucus protects our mucous membranes, keeps them moist, and defends against pathogens – a function that is impaired in diseases such as cystic fibrosis. The special exhibition at the Berlin Medical History Museum showcases why...
A new bioinformatic tool combines the IASLC algorithm with genetic data analysis to more reliably distinguish primary lung tumors from metastases, supporting more accurate staging and treatment decisions in clinical practice.
The DataLung School gathered in Munich for the Lung Science Training 2025, deepening their knowledge of lung biology, disease mechanisms, and data-driven research. The week combined lectures, interactive sessions, and networking across all DZL sites.
Why do some people with asthma experience severe flare-ups after viral infections, while others show hardly any symptoms? DZL researchers have uncovered an underlying mechanism and identified a biomarker that could help predict severe exacerbations...
From new therapeutic approaches to single-cell lung research, the DZL Annual Report 2023/24 demonstrates how close collaboration and innovative research are paving the way for improved treatment options.
At this year’s North American Cystic Fibrosis Conference in Seattle, DZL scientist Prof. Marcus Mall presented new insights into cystic fibrosis and highlighted how precision medicine is advancing treatment of the disease.
The German Research Foundation (DFG) has awarded Dr. Marija Gredić a three-year grant to investigate novel mechanisms driving pulmonary hypertension in COPD. Her work aims to uncover new therapeutic targets to slow or even reverse...
Immunotherapy before surgery could transform lung cancer treatment: DZL researchers report in the NEOMUN study that pembrolizumab can significantly shrink tumors even prior to the procedure.
